Yes I agree CXO way overvalued, but definitely market seems to have overlooked the value ESS present itself with its already defined JORC with further refinement to come End Nov 22. So far it far from being valued ahead of where its at. Same happ with CXO in early days so its a patience game now and have to ride the manipulation that comes with it.
Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-22
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)